Machine learning insights into vaccine adjuvants and immune outcomes

Yuhyun Ji(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Madison Radnoff(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kunal Bakshi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kavitha Bekkari(Merck & Co., Inc., Rahway, NJ, USA (United States)), SamMoon Kim(Merck & Co., Inc., Rahway, NJ, USA (United States)), William J. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jennifer A. Kriss(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jian Xiong(Stanford University), Yaping Liu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shailaa Kummar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Celia LaPorta(Merck & Co., Inc., Rahway, NJ, USA (United States)), Milan Ghodasara(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mohammed Shardar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Geoffrey A. Walford(Merck & Co., Inc., Rahway, NJ, USA (United States)), Willis Read-Button(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicole Sullivan(Merck & Co., Inc., Rahway, NJ, USA (United States))
Frontiers in Immunology
October 7, 2025
10.3389/fimmu.2025.1654060
Cited by 8

Related Papers

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
|Science|2004|1.8k
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
|PLoS Pathogens|2021|215